In short, our results show that the APOBEC family members APOBEC1, APOBEC3A, APOBEC3G and APOBEC3H may play a carcinogenic role in the occurrence and development of PAAD and are expected to become new biomarkers and therapeutic targets of PAAD. This evidence concerns the gene APOBEC3A and pancreatic adenocarcinoma.